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Abstract
The United States healthcare system currently faces an economic challenge related to frequent hospital 
readmission rates. As such, hospitals have begun implementing strategies to reduce readmission rates 
for specific medical conditions such as congestive heart failure, which had a 30-day readmission rate 
of 23.2% in 2014. Patient education and frequent monitoring of symptoms have since allowed patients 
to work together with doctors and nurses to take charge of their healthcare management. Due to heart 
failure clinics and the rise of telemedicine and telemonitoring, heart failure readmission rates have 
since decreased. (Cardiol J)
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Introduction 
Readmission is a major concern for the United 
States (US) healthcare system. Under the Afford-
able Care Act’s Hospital Readmission Reduction 
Program (HRRP), hospital systems are penalized 
monetarily if they have a higher than expected 30-
-day readmission for 6 conditions [1]. The Center 
for Medicare and Medicaid Services (CMS) can 
withhold anywhere from 1% to 3% of Medicare 
reimbursements for the readmissions of conges-
tive heart failure (CHF), coronary artery bypass 
graft surgery, acute myocardial infarction, elective 
primary total hip/knee arthroplasty, pneumonia, 
and chronic obstructive pulmonary disease. Under 
the HRRP, CMS evaluated a total of 3129 hospitals 
for the fiscal year 2020, and 2583 (83%) of these 
hospitals will face penalties, which is estimated at 
$563 million dollars over the course of 1 year [2]. 
In a 2014 comparison of 7-day and 30-day read-
missions by Fingal et al. [3], nearly 10% of Med-
icaid patients with a diagnosis of either CHF or 
schizophrenia were readmitted within 7 days of 
discharge. The top 5 diagnoses with the highest 
30-day readmission rates (n = 27,698,101) were 
as follows: CHF (23.2%), schizophrenia (22.9%), 
respiratory failure (21.6%), alcohol-related disor-
ders (21.5%), iron deficiency and other anemias 
(21.2%) (Fig. 1) [3]. In the US, CHF affects 2–3% 
of the population, with a slightly higher prevalence 
in males (10%) compared to females (8%) [1]. 
Given that the CMS can withhold at least 1% of 
Medicare reimbursement for a diagnosis such as 
heart failure (HF), and the 30-day readmission 
rate for HF is 23.2%, the American healthcare 
system is becoming increasingly burdened with 
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Pathophysiology of  
congestive heart failure
Congestive heart failure is an accumula-
tion of myocardial injury that ultimately leads 
to counterproductive remodeling of the heart 
[4]. CHF results in reduced cardiac output, 
leading to compensatory effects by the body 
through neurohumoral activation and activa-
tion of the sympathetic nervous system (Fig. 2).  
There are two types of HF that commonly present 
in patients: systolic and diastolic. Systolic heart 
Figure 1. Top diagnoses with the highest 30-day read-
mission rates out of 27,698,101 readmissions. Red bar: 
congestive heart failure (CHF) accounts for 23.2% of all 
readmissions within 30 days.
Percentage of readmissions (n = 27.698.101)























Figure 2. Mechanism of congestive heart failure; ADH — antidiuretic hormone; ANP — atrial natriuretic peptide; 
ATII — angiotensin II; BNP — B-type natriuretic peptide; RAAS — renin–angiotensin–aldosterone system; SNS — 
sympathetic nervous system.
failure is referred to as HF with reduced ejection 
fraction (HFrEF), which presents with lower-than-
normal left ventricular ejection fraction on echocar-
diogram [5]. The myocardium is unable to contract 
adequately and, as a result, ejects less oxygen-rich 
blood into the body. Fatigue and shortness of breath 
are common symptoms. In diastolic HF, also known 
as HF with preserved ejection fraction (HFpEF), 
patients present with left ventricular diastolic dys-
function [6]. In HFpEF, the myocardium contracts 
normally but a thickened left ventricle reduces 
compliance, resulting in decreased filling capacity 
and thus cardiac output. Decreased cardiac output 
results in deactivation of the carotid baroreceptors 
and activation of the renin–angiotensin system [7]. 
Angiotensin II increases afterload by activating 
vasoconstriction to the blood vessels, aldosterone 
increases preload by increasing sodium and water 
retention, and antidiuretic hormone stimulates 
water retention [8]. Without B-type natriuretic 
peptide and atrial natriuretic peptide, the water 
retention exacerbates the symptoms of CHF, 
leading to damage of left ventricular remodeling 
to compensate for the increased peripheral resist-
ance [7]. The body compensates by stimulating the 
sympathetic nervous system to increase heart rate 
and contractility, which increases stress on the 
heart. Increasing contractility increases the cardiac 
workload resulting in dilation and hypertrophy of 
the cardiac heart muscle. In a failing heart, the com-
promised ventricles are unable to pump the blood 
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forward to the rest of the body, resulting in fluid 
accumulation into the lungs and the rest of the boy.
Congestive heart failure  
morbidity and mortality rates
In a 2020 updated report from the American 
Heart Association, an estimated 6.2 million Ameri-
cans over the age of 20 years have HF. In 2016, hos-
pital discharges with a diagnosis of CHF numbered 
809,000, and in 2017 the mortality rate from CHF 
was 80,480, a 42% increase from 56,565 in 2007 
[9, 10]. As has been shown, there has been a steady 
increase in mortality from HF (Fig. 3). Heidenreich 
et al. [11] estimated that the medical cost of CHF 
admissions will increase from $20.9 billion in 2012 
to $53.1 billion in 2030, with the majority (80%) 
being attributed to hospitalization. Similarly, their 
projections show the prevalence of HF increasing 
by 46% from 2012 to 2030 [11]. Among Medicare 
patients, the prevalence of HF was 44% in 2010, 
with HF admissions being the costliest preventable 
hospitalization at an average $10,775 [12].
Several factors play roles in the high readmis-
sion rate of CHF. In an analysis done by Inamdar, 
some of the major causes of readmission were 
shown to be due to medication noncompliance, 
smoking, diet noncompliance, failure of documenta-
tion of discharge information and patient education, 
and comorbidities such as hypertension and diabe-
tes mellitus [1]. Under the HRRP, hospitals have 
since been incentivized to come up with strategies 
to decrease the number of readmissions. Some of 
these strategies include multidisciplinary HF clin-
ics, visiting nurse services, physician-directed HF 
transitional care programs, telemonitoring at home, 
and 1-week follow-ups. Inamdar also reports that 
HF clinics reduced all cause readmission rates by 
50% [1]. During the HRRP implementation phase 
the 30-day risk-adjusted readmission rate declined 
from 20% to 18.4%; however, the 30-day mortality 
rate increased from 7.6% to 9.3% [13].
Congestive heart failure clinics  
and outcomes
An important reason why readmission rates 
have effectively decreased is due to outpatient HF 
clinics, home intervention methods, and medica-
tions. Because HF disproportionately affects the 
older population, the management goals focus on 
maintaining and optimizing patient capabilities 
(Central illustration). Several classes of drugs have 
been indicated in the treatment of HF, such as diu-
retics, angiotensin converting enzyme inhibitors, 
and more (Table 1). For CHF patients to remain 
stable after discharge, fluid balance, blood pressure, 
and heart rate must be medically optimized [14]. 
This can be monitored during clinic follow-up or 
at home via implantable devices that transmit data 
to healthcare providers. CHF clinics, commonly 
known as HF clinics, have been developed to help 
patients diagnosed with CHF manage their condi-
tion. By educating patients on their disease and 
encouraging active participation in their treatment, 
one goal is to reduce the need for readmission to 
hospitals for CHF exacerbations. It is important 
that patients being discharged also have a strong 
support system and home environment so that 
they can maintain functional independence. Car-
egivers may also accompany patients to clinic ap-
pointments, thus ensuring proper follow-up after 
discharge. Outpatient clinics can help in educating 
patients and caregivers on weight management, 
medication compliance, dietary changes, and exer-
cise regimens. By seeing a multidisciplinary team 
Figure 3. Heart failure mortality rates in the United States from 2007 to 2017. Trendline shows an increase in mortality 
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Table 1. Drugs commonly used in the treatment of heart failure (HF), their mechanisms of action, and 
effects. 








Competitively inhibit the conversion 
of angiotensin I to angiotensin II, 
inhibit bradykinin metabolism,  
promote sodium and water  
excretion by inhibiting angiotensin II- 
-induced aldosterone secretion
Reduces preload and afterload on 
the heart, exerts reno-protective 
effects via dilation of renal  







Prevents angiotensin II from  
binding to its receptor 




Ivabradine Blocks hyperpolarization-activated 
cyclic nucleotide (HCN) gated 
channel responsible for cardiac 
pacemaker funny current 
Decreases heart rate, cardiac  
output and oxygen demand
Beta-blockers Bisoprolol,  
metoprolol, 
carvedilol
Blocks response to beta-adren-
ergic stimulation by preventing 
ligand binding of the beta-adren-
ergic receptor by norepinephrine 
and epinephrine; cardio selective 
for beta-1 at low doses 
Decreases heart rate, contractility, 
conduction velocity, and relaxation 





Competitively binds receptors at 
aldosterone-dependent sodium-
-potassium (Na-K) exchange site  
in distal renal tubules
Increases excretion of sodium, 
chloride and water; increases  











Loop diuretics: Inhibit cotransport 
of Na-K-2Cl at the thick ascending 
loop of Henle 
Thiazide diuretics: Inhibit sodium-
-chloride transporter at the distal 
renal tubule 
Potassium sparing diuretics:  
Inhibit sodium channels at the  
cortical collecting tubules
Promotes diuresis, depletion  
of sodium and total body  







Sacubitril: neprilysin inhibitor.  
Neprilysin degrades atrial and  
B-type natriuretic peptides  
as well as bradykinin
Valsartan: angiotensin II receptor 
type I inhibitor
Promotes relaxation of blood  
vessels, sodium excretion  
and fluid retention
Central illustration. Key proponents in reducing readmission rates related to congestive heart failure (CHF).











at an HF clinic, a patient’s care is tailored to their 
specific needs. Multidisciplinary teams include a 
cardiologist, specialized HF nurses, pharmacists, 
physiotherapists, social workers, dieticians, and 
other allied health professionals [15]. It is espe-
cially important for patients being discharged to 
be followed up at either their doctor’s office or an 
outpatient clinic for management of their condition. 
Outpatient clinic visits with a physician or health-
care provider after discharge prove to be important 
in reducing readmission for HF. In a Taiwanese 
study of 13,577 HF patients, early follow-up with a 
physician within 7 days of discharge was associated 
with a lower readmission rate (Table 2) [16]. Simi-
larly, an extensive observational analysis conducted 
by Hernandez et al. [17] showed that patients who 
were discharged and received early follow-up with 
a physician had lower 30-day readmission rates. In 
a study comparing patients followed in outpatient 
management vs. no management, only 4 (n = 27) 
managed outpatients were readmitted 5 times, 
whereas 85 (n = 111) patients who did not have 
follow-up accounted for a total of 187 readmissions 
(p < 0.001) [18].
Advent of telemedicine
Due to advancements in digital technology 
and Internet access, coupled with ever changing 
circumstances, telemedicine has recently become 
increasingly popular. Telemedicine is the use of 
video and audio technology, such as phones and 
webcams, to electronically connect a patient to 
a health care provider remotely [19]. Telemedicine 
is used to deliver patient care and provide follow-up 
and education to patients who may not be able to 
visit a doctor’s office as soon as possible. It is not 
only cost effective but it also provides healthcare 
professionals the opportunity to see and talk to 
their patients in real time [20]. The efficacy and 
Table 2. Summary of studies done to evaluate the readmission rates between patients who had  
physician follow-up compared to those without follow-up.
Author Country Study Outcome 
Tung et al.,  
2017
Taiwan 13,775 patients discharged from  
hospitals in 2010 followed for  
association between 7-day  
follow-up and 30-day readmission
Early physician follow-up of HF  
patients was associated with lower 
readmission rates compared to no 
physician follow-up  
(HR 0.54; 95% CI 0.48–0.60)
Hernandez et al., 
2010
United States Observational analysis of patients  
65 years or older with HF
Patients discharged from the  
hospital, who have higher early  
follow-up rates, also have lower  
30-day readmission rates 
Jain et al.,  
2010
United States 138 HF patients during the period 
June 2005 through June 2006 were 
evaluated for outcomes through  
September 2007
4 HF clinic patients (n = 27)  
were readmitted 5 times 
85 non-HF clinic patients (n = 111) 
were readmitted 187 times  
(p < 0.001)
A subgroup analysis of crossovers 
from the non-HF clinic to HF clinic 
group (n = 39) revealed a 60%  
reduction in readmission
Tse et al.,  
2018
United States Systematic review and meta-analysis 
of randomized controlled trials  
and real-world studies  
Telemonitoring reduced hospitalization 
rates of HF patients (n = 31,501)  
by 24% over a 6-month period, and 
by 27% over a 12-month period
Cleland et al.,  
2005
United States Comparison between HTM, NTS,  
and usual care on improving  
outcomes for patients with HF  
who are at high risk of  
hospitalization or death
Similar numbers of admissions and 
mortality among patients in the HTM 
and NTS groups. Patients in the HTM 
group had reduced mean duration of 
admissions by 6 days (95% CI 1–11). 
Patients in the usual care group had 
a higher 1-year mortality (45%) than 
patients in the NTS (27%) and  
HTM (29%) groups (p = 0.032)
CI — confidence interval; HF — heart failure; HR — hazard ratio; HTM — home telemonitoring; NTS — nurse telephone support
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ease of seeing a healthcare professional in the 
comfort of your own home is an opportunity many 
do not pass on. Not only can patients visit with 
a doctor, but they can also talk to behavioral health 
counselors, dieticians, social workers, and other 
professionals while at home. In the management 
of CHF, telemedicine could be utilized to follow 
up patients leaving the hospital, ensuring they are 
receiving adequate care. Healthcare providers can 
also remotely telemonitor and review vitals from 
patient’s in-home devices such as blood pressure 
monitors and pulse oximetry. Telemonitoring is the 
continuous assessment of a medical condition by 
way of home monitoring systems or implantable 
devices that automatically transmit vital signs and 
other physiological data to medical professionals. 
Vital signs can be used to check for decompensated 
HF by measuring parameters such as heart rate, 
blood pressure, heart rate variability, urine output, 
and weight gain [21]. Remote data collection can 
also be done by patient questionnaires that moni-
tor vital signs and symptoms daily. It is not only 
non-invasive but also much easier for a patient to 
continue care in their own home. Home telemoni-
toring has been found to reduce the average num-
ber of days spent in the hospital, and patients who 
received home telemonitoring or nurse telephone 
support had a better 1-year mortality outcome than 
patients who received usual care (p = 0.032) [22]. 
In a meta-analysis by Tse et al. [21], telemonitor-
ing reduced hospitalization rates of HF patients 
(n = 31,501) by 24% over a 6-month period, and 
by 27% over a 12-month period. Providers can also 
utilize hemodynamic monitoring by way of implant-
able cardiac devices, such as CardioMEMS and 
HeartPOD, which continuously transmit cardiac 
or vascular pressures to a remote system that can 
be reviewed. Here, doctors can assess increases 
in intracardiac and pulmonary arterial pressures, 
which may indicate oncoming decompensation of 
HF [21]. Therefore, both telemedicine and telem-
onitoring can be utilized by healthcare profession-
als to effectively assess patients being discharged 
from the hospital. These interventions can reduce 
30-day readmission rates by decreasing the likeli-
hood of CHF exacerbations.
Conclusions
Heart failure costs the US healthcare system 
billions of dollars annually. Hospitalizations are ex-
pensive, and readmission rates have increased the 
burden on hospitals due to decreased compensation 
for readmissions. On the other hand, patients who 
are discharged and do not follow up with a provider 
for management often have poorer outcomes than 
those who do undergo follow-up. Outpatient clinics 
and telemedicine/telemonitoring are crucial for re-
ducing the readmissions rates of patients with HF 
and for achieving better health outcomes. Given 
that some HF patients have significant barriers 
to accessing medical care outside of the hospital, 
such as physical inability, lack of transportation, or 
residing in a rural area, telemedicine provides the 
ability to receive the care they need. Together, clin-
ics and telemedicine/telemonitoring interventions 
help to create a system that works with patients 
to achieve their health goals. We are hopeful that 
telemedicine and outpatient clinics will continue 
to reduce patient’s readmissions and mortality and 
play a key role in caring for the aging population. 
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